Jiangsu Nhwa Pharmaceutical Co., Ltd. Jiangsu Nhwa Pharmaceutical Co., Ltd.

Jiangsu Nhwa Pharmaceutical Co., Ltd.

002262

Rank in Stocks #4734
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Share Price
$3.15
Last synced: 2026-10-20
Market Cap
$3.19B
Change (1 day)
-0.05%
Change (1 year)
-14.01%
Country
CN
Trade Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)

Category

Healthcare
Earnings for Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Earnings in Jun 2026 TTM: $178.32M
According to Jiangsu Nhwa Pharmaceutical Co., Ltd. latest financial reports the company's current earnings are $178.32M. In 2023 the company made an earning of $165.10M, an increase over its 2022 earnings that were of $143.51M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Jiangsu Nhwa Pharmaceutical Co., Ltd. from 2005 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $178.32M 0.37%
2024 $177.65M 7.60%
2023 $165.10M 15.04%
2022 $143.51M -0.40%
2021 $144.08M 10.67%
2020 $130.19M 18.18%
2019 $110.16M 24.59%
2018 $88.42M 29.21%
2017 $68.43M 32.53%
2016 $51.63M 11.41%
2015 $46.35M 10.03%
2014 $42.12M 24.43%
2013 $33.85M 27.40%
2012 $26.57M 38.55%
2011 $19.18M 40.39%
2010 $13.66M 48.52%
2009 $9.20M 26.55%
2008 $7.27M 35.65%
2007 $5.36M 134.21%
2006 $2.29M 10.87%
2005 $2.06M 0.00%
Earnings for similar companies or competitors